The California State Assembly Committee on Labor and Employment recently held an informational hearing on the subject of workplace conditions in retail pharmacies. Among those testifying were pharmacists, academics, students, consumer advocates, and representatives of the California Retailers Association.
The National Community Pharmacists Association (NCPA) is still working to urge Congress to exempt community pharmacies from the Oct. 1 accreditation and surety bond requirements needed to continue providing durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) to Medicare patients.
Orlando, Fla.? National health care reform and the growth of generic drugs were the top issues noted by McKesson U.S. Pharmaceutical executives during this week's pharmacy strategies conference here.
On July 20, Steven C. Anderson, president and chief executive officer of the National Association of Chain Drug Stores (NACDS), sent a letter to political leaders regarding the America's Affordable Health Choices Act.
Congress gave the Food and Drug Administration (FDA) jurisdiction over tobacco in June, but don?t look for any quick changes in tobacco policy, products, or marketing. The agency is asking the public for guidance before jumping into regulation.
So what is actually happening behind the retail counter? To get an idea, Drug Topics took a brief, unscientific survey of individual community pharmacists. All the respondents felt that pharmacist counseling reduces medication errors.
As of June 2009, it appears that North Carolina remains the only state to require any consistent public reporting of pharmacy-associated medication errors. In North Carolina, pharmacists must report errors associated with deaths.
Record budget problems have pushed California to eliminate funding for the largest poison control system in the nation. Keep reading to find out about a California pharmacy's fight to keep the poison control system going.
CVS, Merck, and Pfizer are just a few of the pharmaceutical heavyweights working together to electronically trace pharmaceutical products through the healthcare supply chain.
More than 80 community pharmacists from the National Community Pharmacists Association (NCPA) and several patients met with the Federal Trade Commission (FTC) May 13 to discuss concerns about the impact of the March 2007 CVS/Caremark merger and to urge the FTC to re-examine it.